C
262.40
-1.80 (-0.68%)
| 前收盘价格 | 264.20 |
| 收盘价格 | 263.00 |
| 成交量 | 1,084,201 |
| 平均成交量 (3个月) | 6,930,791 |
| 市值 | 5,364,347,904 |
| 市盈率 (P/E TTM) | 37.49 |
| 预期市盈率 (P/E Forward) | 20.62 |
| 价格/销量 (P/S) | 3.25 |
| 股市价格/股市净资产 (P/B) | 4.38 |
| 52周波幅 | |
| 利润日期 | 29 Jul 2025 |
| 股息率 (DY TTM) | 0.02% |
| 营业毛利率 | 8.32% |
| 营业利益率 (TTM) | 16.55% |
| 稀释每股收益 (EPS TTM) | 0.070 |
| 季度收入增长率 (YOY) | 8.20% |
| 季度盈利增长率 (YOY) | 50.00% |
| 总债务/股东权益 (D/E MRQ) | 71.18% |
| 流动比率 (MRQ) | 1.55 |
| 营业现金流 (OCF TTM) | 396.20 M |
| 杠杆自由现金流 (LFCF TTM) | 309.75 M |
| 资产报酬率 (ROA TTM) | 6.06% |
| 股东权益报酬率 (ROE TTM) | 11.27% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (GB) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 看跌 | |
| 股票 | CONVATEC GROUP PLC ORD 10P | - | - |
AIStockmoo 评分
0.6
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.63 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| CONVATEC GROUP PLC ORD 10P | 5 B | 0.02% | 37.49 | 4.38 |
| BECTON DICKINSON AND CO BECTON | 47 B | 2.27% | 27.35 | - |
| RESMED INC RESMED ORD SHS | 35 B | 0.80% | 47.35 | - |
| HOLOGIC INC HOLOGIC ORD SHS | 16 B | - | 10.10 | - |
| COOPER COMPANIES INC COOPER ORD | 4 B | - | 4.31 | - |
| TECAN GROUP AG TECAN GROUP ORD | 2 B | 1.87% | 16.55 | - |
|
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Mid Core |
| 内部持股比例 | 19.75% |
| 机构持股比例 | 64.80% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合